6-Bromo-2,3-dichloroquinoxaline

Catalog No.: 
ACYPMK581
CAS No.: 
108229-82-9
Molecular Formula: 
C8H3BrCl2N2
Molecular Weight: 
277.94
6-Bromo-2,3-dichloroquinoxaline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$110.00In stockIn stock
5g95%$549.00In stockIn stock
25g95%$2375.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Bromo-2,3-dichloroquinoxaline
IUPAC Name6-bromo-2,3-dichloroquinoxaline
MDL No.MFCD09842518
Molecular FormulaC8H3BrCl2N2
Molecular Weight277.94
SMILESClC1=NC2=CC(Br)=CC=C2N=C1Cl
InChI KeyPSSGUHOTRLMJNO-UHFFFAOYSA-N
Synonym6-bromo-2,3-dichloroquinoxaline;7-bromo-2,3-dichloroquinoxaline;Quinoxaline, 6-bromo-2,3-dichloro-
CAS No.108229-82-9
PubChem CID13799585

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACYPMK581 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUYWH283 route compound structure diagram
    ACUYWH2831910-90-3In Stock
  2. Then
  3. ACYPMK581 route product structure diagram
    ACYPMK581108229-82-9In Stock
Inquiry

2. ACYPMK581 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDTQJ324 route compound structure diagram
    ACDTQJ3247447-41-8In Stock
  2. Plus
  3. ACYPMK581 route compound structure diagram
    ACYPMK581108229-82-9In Stock
  4. Then
  5. ACYPMK581 route product structure diagram
    ACYPMK581108229-82-9In Stock
Inquiry

3. ACYPMK581 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDUEF916 route compound structure diagram
    ACDUEF91613484-50-9In Stock
  2. Plus
  3. ACEGJX062 route compound structure diagram
    ACEGJX0625467-74-3In Stock
  4. Then
  5. ACYPMK581 route product structure diagram
    ACYPMK581108229-82-9In Stock
Inquiry

Comments (0)